SCHEMBL4132769

SCHEMBL4132769

CCCc1nn(C)c2c(=O)[nH]c(N(Cc3ccc(Cl)c(Cl)c3)CC3CCCCC3)nc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 17/20 0.42
PDE3A Q14432 4/20 0.42
PDE3B Q13370 3/20 0.42
MTOR P42345 1/20 0.40
HDAC6 Q9UBN7 3/20 0.39
HDAC1 Q13547 2/20 0.39
PDE1A P54750 2/20 0.39
PDE1B Q01064 2/20 0.39
PDE1C Q14123 2/20 0.39
PDE6C P51160 2/20 0.39
PDE2A O00408 1/20 0.39
ABCC4 O15439 1/20 0.39
ABCC5 O15440 1/20 0.39
PDE6D O43924 1/20 0.39
PDE8A O60658 1/20 0.39
PDE9A O76083 1/20 0.39
ABCB11 O95342 1/20 0.39
CYP3A4 P08684 1/20 0.39
HTR1A P08908 1/20 0.39
PDE6A P16499 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4136868 0.85 PDE5A (0.44) PDE5APDE3APDE3BMTORHDAC6
SCHEMBL8049072 0.85 PDE5A (0.48) PDE5APDE3APDE3BMTORHDAC6
SCHEMBL4897792 0.85 PDE5A (0.46) PDE5APDE3APDE3BMTORHDAC6
SCHEMBL8037857 0.84 PDE5A (0.42) PDE5APDE3APDE3BMTORHDAC6
SCHEMBL4902249 0.82 PDE5A (0.49) PDE5APDE3APDE3BMTORHDAC6
SCHEMBL4902063 0.82 PDE5A (0.44) PDE5APDE3APDE3BMTORHDAC6
SCHEMBL4128912 0.82 PDE5A (0.41) PDE5APDE3APDE3BMTORHDAC6
SCHEMBL3993298 0.81 PDE5A (0.44) PDE5APDE3APDE3BMTORHDAC6
SCHEMBL4133812 0.80 PDE5A (0.42) PDE5APDE3APDE3BMTORHDAC6
SCHEMBL4134650 0.80 PDE5A (0.51) PDE5APDE3APDE3BMTORHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed